Latest Articlesddd
Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …
Outperforming Biotechs On August 27, 2019 we posted “The Medicines Company Has Agreeable News” under Today’s …
Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …
The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …
Amgen Agreement with Celgene for Otezla® In the News Amgen (AMGN) entered into an agreement with …
AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca (AZN) has good news. Many of them …
From Moderna From the press release we learned that the U.S. Food and Drug Administration (FDA) …
The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …
Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved …
Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …
Palm Ebola Clinical Trial Stopped Early as Regeneron Product REGN-EB3 Therapy Shows Superiority to ZMapp in …
Prohost Letter #434 Special Issue The Value of the Biotech Companies With a strong economy and …
Amgen’s Stock Is Up Amgen (AMGN) is speeding towards reaching its true, fair value. In the Q2 …
Press Release Amgen Wins Patent Case On Enbrel® (etanercept) Court Upholds Validity of Patent Claims Directed …
Nektar Therapeutics Story Everything was going well with Nektar Therapeutics (NKTR) stock during the Conference call …
Nektar Press Release Nektar Therapeutics Results for Q2 of 2019 Nektar Therapeutics (Nasdaq: NKTR) reported its financial …
The News Prohost Was Waiting for to Post Its Special Letter Prohost has one eye on …
Rhythm Pharmaceuticals From Rhythm Pharmaceuticals (RYTM) we learned that positive, top-line results from two pivotal Phase 3 …
What Have We Learned from the Market's Recent Stock Moves? Well. Did we learn anything from …
In This Column Every day thousands of press releases are issued about biotechnology and pharmaceutical firms. …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
